Core Viewpoint - Rosen Law Firm is reminding investors who purchased V.F. Corporation securities during the specified class period of the upcoming lead plaintiff deadline on November 12, 2025 [1] Group 1: Class Action Details - Investors who bought V.F. Corporation securities between October 30, 2023, and May 20, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6] - The lawsuit alleges that V.F. Corporation's management provided misleading information regarding the company's turnaround plans, particularly concerning the Vans brand [5] Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4] - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019, and has been consistently ranked among the top firms in securities class action settlements [4] Group 3: Case Specifics - The lawsuit claims that V.F. Corporation's management concealed necessary actions that would impact the revenue growth trajectory of the Vans brand, leading to investor damages when the truth was revealed [5]

Core Viewpoint - Nutex Health Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025, impacting investors adversely [1][2]. Group 1: Allegations and Company Impact - The lawsuit claims that Nutex Health Inc. made false statements regarding its third-party vendor HaloMD, which allegedly engaged in fraudulent activities to achieve favorable arbitration results [1]. - It is alleged that revenues from Nutex's engagement with HaloMD were unsustainable due to the fraudulent nature of the conduct [1]. - The company purportedly overstated its ability to remediate material weaknesses in its internal controls over financial reporting, leading to improper accounting of stock-based compensation obligations [1]. - As a result of these issues, Nutex Health Inc. may have overstated its business and financial prospects, making public statements materially false and misleading [1]. Group 2: Legal Proceedings and Participation - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [2]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [2].

Core Viewpoint - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following issues related to its acquisition of Pro-ficiency Holdings, Inc. and subsequent financial reporting problems [1][2][3]. Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2]. - The company acquired Pro-ficiency Holdings in June 2024, aiming to double its total addressable market and enhance sales [2][3]. Financial Reporting Issues - Simulations Plus claimed effective internal controls over financial reporting; however, it appears the company struggled with the integration of Pro-ficiency and lacked effective internal controls [3]. - On April 15, 2025, the company appointed Grant Thornton LLP as its new auditor, which later raised concerns regarding the company's financial reporting [4][5]. Stock Performance - Following the announcement of disappointing preliminary financial results for Q3 2025 on June 11, 2025, Simulations Plus's stock price dropped by over 24%, from $26.44 to $20.05 per share [4]. - The company reported a $77.2 million charge related to prior acquisitions on July 14, 2025, leading to a further decline in stock price by nearly 26%, from $17.47 to $12.97 per share [5].

Core Viewpoint - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial results and issues related to its acquisition of Pro-ficiency Holdings, Inc. [1][2][3] Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2]. Acquisition Details - In June 2024, Simulations Plus acquired Pro-ficiency Holdings, which was expected to double its total addressable market and significantly contribute to sales [2][3]. Financial Reporting Issues - The company claimed effective internal controls over financial reporting; however, it appears there were struggles with the integration of Pro-ficiency and deficiencies in internal controls [3]. Stock Performance - Following the announcement of disappointing preliminary financial results for Q3 2025, Simulations Plus's stock fell by $6.39, or over 24%, from $26.44 to $20.05 per share [4]. - After reporting a $77.2 million charge related to prior acquisitions and dismissing its auditor Grant Thornton, the stock further declined by $4.50, nearly 26%, from $17.47 to $12.97 per share [5]. Auditor Dismissal - The dismissal of Grant Thornton was linked to unresolved issues regarding segment reporting and internal controls, which the auditor communicated to management and the Audit Committee [5].

Group 1 - CarMax, Inc. is under investigation for potential violations of federal securities laws by Bleichmar Fonti & Auld LLP [1] - The investigation stems from claims that CarMax misrepresented the sustainability of demand for its used cars, which was temporarily boosted by U.S. tariffs [2] - Following the announcement of disappointing Q2 2025 earnings, CarMax experienced significant stock declines, with a 20% drop from $57.05 to $45.60 per share [3] Group 2 - In Q2 2025, CarMax reported a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [3] - The company's net earnings for Q2 were approximately $95.4 million, down from $132.8 million in the previous year, attributed to a "pull forward" in demand due to tariff announcements [3]

Core Viewpoint - Fly-E Group, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between July 15, 2025, and August 14, 2025 [1][2] Summary by Sections Class Action Lawsuit - The lawsuit aims to recover losses for Fly-E investors affected by alleged securities fraud during the specified period [1] - Investors can contact Levi & Korsinsky for more information and assistance [1] Case Details - Defendants allegedly made overly positive statements while concealing material adverse facts about the safety of Fly-E's lithium battery, which affected E-vehicle sales revenue [2] - Fly-E's revenue projections were derailed as sales declined and operating expenses increased [2] - On August 14, 2025, Fly-E reported a 32% decrease in net revenues, primarily due to a drop in total units sold, linked to recent lithium-battery accidents [2] - Following this revelation, Fly-E's stock price plummeted from $7.76 to $1.00 per share, a decline of approximately 87% in one day [2] Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until November 10, 2025, to request appointment as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Tronox Holdings plc during the specified Class Period of the upcoming lead plaintiff deadline on November 3, 2025 [1]. Group 1: Class Action Details - Investors who bought Tronox common stock between February 12, 2025, and July 30, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit alleges that Tronox provided misleading statements about its commercial division and failed to accurately forecast demand for its products, leading to investor losses when the true situation was revealed [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4].

Group 1 - The Rosen Law Firm is reminding purchasers of Tronox Holdings plc common stock from February 12, 2025, to July 30, 2025, about the lead plaintiff deadline on November 3, 2025 [1][2][3] - Investors who purchased Tronox common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5] - A class action lawsuit has already been filed against Tronox, alleging that the company provided misleading statements about its commercial division and failed to accurately forecast demand for its products, leading to investor damages [5][6] Group 2 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4][5] - The firm has been recognized for its performance in securities class action settlements, including a record settlement against a Chinese company and being ranked highly in the industry for multiple years [4][5] - Investors are informed that no class has been certified yet, and they have the option to select their counsel or remain absent from the class [7]

Core Viewpoint - A securities fraud class action lawsuit has been filed against Fly-E Group, Inc. for alleged misrepresentations regarding the safety of its lithium battery, affecting investors who purchased securities between July 15, 2025, and August 14, 2025 [3]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Eastern District of New York, targeting Fly-E and certain senior officers for violations of the Securities Exchange Act of 1934 [3]. - Investors are reminded of a deadline to file as lead plaintiff by November 7, 2025, which allows them to represent other class members in the litigation [4]. Group 2: Investor Information - Investors who acquired Fly-E securities during the specified period are encouraged to discuss their legal rights and options [2]. - All representation in the lawsuit is on a contingency fee basis, meaning shareholders will not incur fees or expenses unless there is a recovery [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized multiple times for its success in litigating class actions [5].

Core Viewpoint - Tronox Holdings plc is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 12, 2025, and July 30, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and forecasting processes, which ultimately led to declining sales and increased costs [2]. - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales for the second quarter, attributing the decline to a softer coatings season and heightened competition, which resulted in a lowered financial outlook and a 60% reduction in dividends [2]. - Following the announcement, Tronox's stock price plummeted from $5.14 to $3.19 per share, marking a decline of approximately 38% in just one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].